Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China WTO accession

This article was originally published in The Gray Sheet

Executive Summary

Bilateral U.S.-Chinese agreement on China's accession to the World Trade Organization, announced Nov. 15, is expected to eliminate barriers hampering the medical technology industry's access to the Chinese market. Elimination of high tariffs, regulatory obstacles and distribution and import barriers is expected to make it possible for companies to provide basic medical care and technological innovations to the Chinese people, including development of health care insurance companies and hospitals. Both the Health Industry Manufacturers Association and Chindex International, Inc. applauded the agreement in releases Nov. 16 and 18 respectively. HIMA is participating in a Nov. 30 WTO ministerial conference in Seattle "in an accredited non-governmental advisory role"

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012598

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel